Alembic Pharmaceuticals, Inc. is recalling 2,844 units of Diclofenac Sodium Topical Solution USP, 2% w/w. This prescription medication, which is used to treat pain, is being recalled because the bottle's delivery system is defective. If you have this product, you should contact your healthcare provider or pharmacist for guidance regarding your treatment.
A defective delivery system can prevent the medication from being dispensed correctly, which may result in an inaccurate dose or an inability to access the treatment.
You have 2 options:
Manufactured for Alembic Pharmaceuticals, Inc. Bedminster, NJ. Manufactured by Alembic Pharmaceuticals Limited (Derma Division) India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.